Clinical trials
Sepsis clinical trials
Below are recruiting sepsis clinical trials, each written for real people, not researchers. We’re tracking 268 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06473844Recruiting
SGLT2 inhibitors for adults with sepsis
This trial tests whether a type of diabetes medicine (SGLT2 inhibitors) can help adults with sepsis, a life-threatening response to infection. If you have new-onset sepsis and can take oral medicine, you may be eligible.
Hong Kong, Hong KongAges 18 years+ - NCT06512129Recruiting
Measuring fluid levels in sepsis patients
This study measures fluid levels outside your cells to better understand and manage sepsis. It may help doctors give the right amount of fluids during treatment.
Uppsala, UppsaAges 18 years+ - NCT06514339RecruitingEarly Phase 1
Shenhuang granules for sepsis treatment
This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.
Hangzhou, ZhejiangAges 18 years+ - NCT06524622Recruiting
Ultrasound and pressure test for sepsis in the ICU
This study tests whether a special ultrasound exam (VExUS) combined with a standard pressure measurement (CVP) can better predict outcomes for people with sepsis in the ICU. The goal is to see if these tools help doctors make better treatment decisions.
Yibin, SichuanAges 18–100 - NCT06562803Recruiting
Cleaning the blood for liver failure with sepsis
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
Guangzhou, GuangdongAges 18–70 - NCT06624618Recruiting
Fast DNA test for sepsis in the ICU
This study tests a quick DNA-based test to find bloodstream infections in ICU patients. If you are getting standard blood cultures for a suspected infection, you may be able to join.
Maastricht, LimburgAges 18 years+ - NCT06657781Recruiting
Platelet function study in patients with sepsis
This study looks at how platelets (small cells that help blood clot) behave in people with severe infections (sepsis). It explores a specific part of the immune system (inflammasome) linked to platelet activation, which may help develop better treatments for serious infections.
Les Abymes, GuadeloupeAges 18 years+ - NCT06666946Recruiting
Electroacupuncture for sepsis patients in the ICU
This study tests whether gentle electrical stimulation through thin needles placed in the lower legs (electroacupuncture) can help patients fight sepsis in the ICU. It aims to see if this treatment reduces organ damage and speeds recovery.
Wuhan, HubeiAges 18 years+ - NCT06670963RecruitingPhase 4
Epoetin alfa and iron for anemia in sepsis
This trial tests whether a combination of epoetin alfa (a medicine that boosts red blood cell production) and iron derisomaltose (an iron supplement) can safely treat anemia in people with sepsis or septic shock. It may help improve your energy and recovery.
KatowiceAges 18 years+ - NCT06686355RecruitingPhase 2
Yiqilishui formula for sepsis-related heart problems
This trial tests a Chinese herbal formula called Yiqilishui in people with sepsis who have developed heart muscle weakness. It aims to see if the formula can help improve heart function.
BeijingAges 50–85 - NCT06689189Recruiting
Detecting sepsis early with blood fluorescence
This trial uses a blood fluorescence test to check for early signs of sepsis. It may help doctors diagnose sepsis faster, allowing for quicker treatment.
Ningbo, ZhejiangAges 18 years+ - NCT06712641RecruitingPhase 4
Testing aminoglycoside antibiotics for early sepsis
This trial tests a type of antibiotic called aminoglycosides to treat early sepsis (a serious infection). It is for adults in the hospital who are sick enough to need strong antibiotics but not in the worst stage of the illness.
Bergen, BergenAges 18 years+ - NCT06745115Recruiting
Using blood fluorescence to detect sepsis
This trial tests a new way to detect sepsis using fluorescence from a blood sample. It may help doctors identify sepsis earlier and improve treatment.
Guangzhou, GuangdongAges 18 years+ - NCT06749483Recruiting
Gut bacteria and infection in intensive care patients
This study looks at how gut bacteria affect severe infections in the ICU. It tests whether the microbiome can be a source of sepsis and a target for treatment. If you are critically ill or a long-term sepsis survivor, you might help find new ways to prevent infections.
Jena, ThuringiaAges 18 years+ - NCT06817408Recruiting
Organ Damage and Immune Exhaustion in Sepsis
This study looks at how sepsis (a severe infection) affects organs and the immune system over time. It may help find better ways to treat people who have had a septic shock.
Rochester, MinnesotaAges 18 years+ - NCT06854640RecruitingPhase 1
Safety and dosing study for a new sepsis-related blood clotting treatment
This study tests a new drug (BAY 3389934) for people with sepsis who also have a blood clotting problem. It aims to find the right dose and make sure the drug is safe.
EdegemAges 18–80 - NCT06860438Recruiting
Using a new monitor to guide blood pressure meds in sepsis
This study looks at a special blood flow monitor (perfusion index) to see if it can help doctors decide when to give blood pressure raising medicines in patients with serious infections. It might help doctors better treat sepsis and septic shock.
CairoAges 18 years+ - NCT06882811RecruitingEarly Phase 1
Stem cell treatment for sepsis
This trial tests a treatment made from human umbilical cord cells to help the body fight severe infections (sepsis). It might reduce inflammation and improve recovery.
Chongqing, Chongqing MunicipalityAges birth–65 years - NCT06891599Recruiting
Blood test for clotting in sepsis and trauma ICU patients
This study is testing a special blood test called ROTEM to see how well it can predict bleeding problems in ICU patients with sepsis or severe trauma. It may help doctors give the right treatment faster.
StockholmAges 18 years+ - NCT06915974Recruiting
Comparing Blood Tests for Sepsis in Burn ICU Patients
This study is comparing two blood tests (Interleukin 6 and Procalcitonin) to find which is better at detecting sepsis (a serious infection) and predicting the risk of death in burn patients in the ICU. If you have moderate burns and are otherwise healthy, this trial could help improve care for burn victims.
CairoAges 25–60 - NCT06943326Recruiting
How food given through a tube affects recovery in sepsis patients
This trial tests if the type of tube feeding given to sepsis patients in the ICU can affect their recovery. It aims to find the best diet to help fight the infection and prevent complications.
SanliurfaAges 18 years+ - NCT06963853Recruiting
Study of infection and body chemicals in dialysis patients with sepsis
This study looks at germs and body chemicals in dialysis patients who are in the hospital with sepsis. The goal is to learn more about how these factors affect recovery.
Nahariya, IsraelAges 18 years+ - NCT07009665Recruiting
Fluid management in sepsis patients at the emergency department
This study tests a personalized approach to giving fluids to patients with sepsis, a serious infection that can cause low blood pressure. The goal is to see if individualized fluid resuscitation improves outcomes compared to standard care.
Groningen, Provincie GroningenAges 18 years+ - NCT07022041Recruiting
Sepsis and survival in heart patients
This study looks at how sepsis and other infections affect survival in hospitalized heart patients. It is designed for people who are being treated for a heart condition and either have no infection or have a specific type of infection or heart inflammation.
CosenzaAges 18 years+
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for sepsis?
- Yes. Clin2 currently lists 268 recruiting sepsis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a sepsis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a sepsis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.